Abstract
OBJECTIVE The aim of this study was to demonstrate the in vivo safety and antitumor effect of a novel recombinant vesicular stomatitis virus (VSV): G protein less (GLESS)–fusion-associated small transmembrane (FAST)–VSV.
Author supplied keywords
Cite
CITATION STYLE
APA
Jiang, B., Huang, D., He, W., Guo, W., Yin, X., Forsyth, P., … Wang, Z. (2021). Inhibition of glioma using a novel non-neurotoxic vesicular stomatitis virus. Neurosurgical Focus, 50(2), 1–8. https://doi.org/10.3171/2020.11.FOCUS20839
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free